CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 159 filers reported holding CONMED CORP in Q1 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,965,104 | -13.7% | 57,200 | -0.3% | 0.04% | -6.5% |
Q1 2024 | $4,596,592 | -26.9% | 57,400 | 0.0% | 0.05% | -31.3% |
Q4 2023 | $6,285,874 | +8.3% | 57,400 | -0.3% | 0.07% | 0.0% |
Q3 2023 | $5,803,918 | -25.8% | 57,550 | 0.0% | 0.07% | -18.3% |
Q2 2023 | $7,820,470 | +29.7% | 57,550 | -0.9% | 0.08% | +26.2% |
Q1 2023 | $6,029,073 | +17.2% | 58,050 | 0.0% | 0.06% | +18.2% |
Q4 2022 | $5,145,552 | +10.6% | 58,050 | 0.0% | 0.06% | 0.0% |
Q3 2022 | $4,654,000 | -16.3% | 58,050 | 0.0% | 0.06% | -9.8% |
Q2 2022 | $5,559,000 | -36.0% | 58,050 | -0.7% | 0.06% | -21.8% |
Q1 2022 | $8,683,000 | +3.2% | 58,450 | -1.5% | 0.08% | +8.3% |
Q4 2021 | $8,413,000 | +8.1% | 59,350 | -0.3% | 0.07% | +4.3% |
Q3 2021 | $7,784,000 | -4.8% | 59,500 | 0.0% | 0.07% | 0.0% |
Q2 2021 | $8,177,000 | +1.5% | 59,500 | -3.6% | 0.07% | -2.8% |
Q1 2021 | $8,057,000 | +15.7% | 61,700 | -0.8% | 0.07% | +9.2% |
Q4 2020 | $6,966,000 | +40.8% | 62,200 | -1.1% | 0.06% | +18.2% |
Q3 2020 | $4,948,000 | +8.7% | 62,900 | -0.5% | 0.06% | +5.8% |
Q2 2020 | $4,550,000 | +24.1% | 63,200 | -1.2% | 0.05% | +20.9% |
Q1 2020 | $3,665,000 | -49.5% | 64,000 | -1.4% | 0.04% | -25.9% |
Q4 2019 | $7,258,000 | +12.2% | 64,900 | -3.6% | 0.06% | +7.4% |
Q3 2019 | $6,471,000 | +7.6% | 67,300 | -4.3% | 0.05% | +17.4% |
Q2 2019 | $6,016,000 | +0.9% | 70,300 | -2.0% | 0.05% | +2.2% |
Q1 2019 | $5,964,000 | +27.8% | 71,700 | -1.4% | 0.04% | +15.4% |
Q4 2018 | $4,667,000 | -19.0% | 72,700 | 0.0% | 0.04% | 0.0% |
Q3 2018 | $5,759,000 | +2.0% | 72,700 | -5.7% | 0.04% | 0.0% |
Q2 2018 | $5,644,000 | +12.3% | 77,100 | -2.9% | 0.04% | +14.7% |
Q1 2018 | $5,028,000 | +11.6% | 79,400 | -10.2% | 0.03% | +21.4% |
Q4 2017 | $4,506,000 | -3.1% | 88,400 | -0.2% | 0.03% | -3.4% |
Q3 2017 | $4,649,000 | +3.0% | 88,600 | 0.0% | 0.03% | 0.0% |
Q2 2017 | $4,513,000 | +14.7% | 88,600 | 0.0% | 0.03% | +16.0% |
Q1 2017 | $3,935,000 | +0.6% | 88,600 | 0.0% | 0.02% | 0.0% |
Q4 2016 | $3,913,000 | +10.0% | 88,600 | -0.2% | 0.02% | +8.7% |
Q3 2016 | $3,557,000 | -16.1% | 88,800 | 0.0% | 0.02% | -17.9% |
Q2 2016 | $4,238,000 | +13.8% | 88,800 | 0.0% | 0.03% | +12.0% |
Q1 2016 | $3,724,000 | -5.5% | 88,800 | -0.8% | 0.02% | -3.8% |
Q4 2015 | $3,942,000 | -8.0% | 89,500 | -0.3% | 0.03% | -7.1% |
Q3 2015 | $4,287,000 | -18.3% | 89,800 | -0.3% | 0.03% | 0.0% |
Q2 2015 | $5,250,000 | +13.4% | 90,100 | -1.7% | 0.03% | +16.7% |
Q1 2015 | $4,630,000 | +12.3% | 91,700 | 0.0% | 0.02% | +14.3% |
Q4 2014 | $4,123,000 | +21.5% | 91,700 | -0.4% | 0.02% | +16.7% |
Q3 2014 | $3,393,000 | -16.7% | 92,100 | -0.2% | 0.02% | -14.3% |
Q2 2014 | $4,075,000 | +0.8% | 92,300 | -0.8% | 0.02% | -4.5% |
Q1 2014 | $4,041,000 | +2.0% | 93,000 | -0.2% | 0.02% | +4.8% |
Q4 2013 | $3,961,000 | +24.2% | 93,200 | -0.7% | 0.02% | +10.5% |
Q3 2013 | $3,189,000 | +8.7% | 93,900 | 0.0% | 0.02% | +5.6% |
Q2 2013 | $2,933,000 | – | 93,900 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |